SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171843-21-007471
Filing Date
2021-11-03
Accepted
2021-11-03 16:33:25
Documents
5
Period of Report
2021-08-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3189
2 EXHIBIT 24 exh_24.htm EX-24 5893
3 GRAPHIC exh24_01.jpg GRAPHIC 467052
4 GRAPHIC exh24_02.jpg GRAPHIC 106179
5 GRAPHIC exh24_03.jpg GRAPHIC 67300
  Complete submission text file 0001171843-21-007471.txt   881112
Mailing Address
Business Address
HASELTINE WILLIAM A (Reporting) CIK: 0000938807 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35776 | Film No.: 211375988

Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Issuer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations